Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

3
results for

"Supplementation"

Article category

Keywords

Publication year

Authors

"Supplementation"

Review Article

[English]
Dose-Dependent Impacts of Omega-3 Fatty Acids Supplementation on Anthropometric Variables in Patients With Cancer: Results From a Systematic Review and Meta-Analysis of Randomized Clinical Trials
Seyed Mojtaba Ghoreishy, Sheida Zeraattalab-Motlagh, Reza Amiri Khosroshahi, Amirhossein Hemmati, Morvarid Noormohammadi, Hamed Mohammadi
Clin Nutr Res 2024;13(3):186-200.   Published online July 29, 2024
DOI: https://doi.org/10.7762/cnr.2024.13.3.186

Meta-analyses have been conducted with conflicting results on this topic. Due to missing several eligible studies in previous meta-analysis by Lam et al., we conducted an extensive systematic review and dose-response meta-analysis of randomized controlled trials in this regard. A comprehensive search was conducted across various databases, including MEDLINE/PubMed, ISI Web of Knowledge, Scopus, and Google Scholar, until November 2023. Based on the analysis of 33 studies comprising 2,047 individuals, it was found that there was a significant increase in body weight for each 1 g/day increase in omega-3 lipids (standardized MD [SMD], 0.52 kg; 95% confidence interval [CI], 0.31, 0.73; I2 = 95%; Grading of Recommendations Assessment, Development and Evaluation [GRADE] = low). Supplementation of omega-3 fatty acids did not yield a statistically significant impact on body mass index (BMI) (SMD, 0.12 kg/m2; 95% CI, −0.02, 0.27; I2 = 79%; GRADE = very low), lean body mass (LBM) (SMD, −0.02 kg; 95% CI, −0.43, 0.39; I2 = 97%; GRADE = very low), fat mass (SMD, 0.45 kg; 95% CI, −0.25, 1.15; I2 = 96%; GRADE = low), and body fat (SMD, 0.30%; 95% CI, −0.90, 1.51; I2 = 96%; GRADE = very low). After excluding 2 studies, the findings were significant for BMI. Regarding the results of the dose-response analysis, body weight increased proportionally by increasing the dose of omega-3 supplementation up to 4 g/day. Omega-3 fatty acid supplementation can improve body weight, but not BMI, LBM, fat mass, or body fat in cancer patients; large-scale randomized trials needed for more reliable results.

Trial Registration

PROSPERO Identifier: CRD42023395341

Citations

Citations to this article as recorded by  
  • Nutritional impact of eicosapentaenoic acid supplementation (EPA) in patients with locally advanced head and neck cancer: a double-blind placebo-controlled randomized trial
    Lorena Arribas, Laura Hurtós, Anna Esteve, Inmaculada Peiró, Ana Regina González-Tampán, Maryam Choulli, Maite Antonio, Esther Vilajosana, Alicia Lozano Borbalas, Miren Taberna, Ricard Mesía
    Nutrition Journal.2025;[Epub]     CrossRef
  • A Complete Examination of Omega-3 Full of Fat Acids: Their Origin, Activities, Well Being Advantages
    Ashutosh Pathak*1&2
    Journal of Science Innovations and Nature of Earth.2025; 5(1): 05.     CrossRef
  • An Overview of the Importance of Muscle Health in Oncology: Assessment, Preservation, and Nutritional Recovery Strategies
    Larissa Farinha Maffini, Camilla Horn Soares, Amanda Guterres Beuren, Gabriel Tonin Ferrari, Heloisa Jacques Friedrich, Giovana Breitenbach Camargo, Giovanna Strapasson Faccin, Carolina Pagnoncelli Gabrielli, Giovanna Potrick Stefani, Viviani Ruffo de Oli
    Current Nutrition Reports.2025;[Epub]     CrossRef
  • Omega-3 Supplementation and Nutritional Status in Patients with Pancreatic Neoplasms: A Systematic Review
    Luciana Pires, Luciane Salaroli, Olívia Podesta, Fabiano Haraguchi, Luís Lopes-Júnior
    Nutrients.2024; 16(23): 4036.     CrossRef
  • 24 View
  • 0 Download
  • 4 Crossref
Original Articles
[English]
The Effect of Arginine Intake on Colorectal Cancer: a Systematic Review of Literatures
Jahangir Karimian, Amir Hadi, Ammar Salehi-sahlabadi, Marzieh Kafeshani
Clin Nutr Res 2019;8(3):209-218.   Published online July 25, 2019
DOI: https://doi.org/10.7762/cnr.2019.8.3.209

Colorectal cancer (CRC) is one of the major reasons of mortality in the worldwide. There is clear evidence that some amino acids such as arginine can improve CRC and its complications. Hence, in this systematic review we evaluated the association between arginine intake and CRC improvement. We searched the PubMed, Scopus, ISI Web of Science, Cochrane library, and Google Scholar databases by using proper keywords to find the relevant literatures, published to March 2019. Nine human studies of 523 screened articles were included in present systematic review. The majority of studies have found a positive association between consumption of arginine and CRC improvement. Increased inducible nitric oxide (NO) synthase expression and subsequently increasing the NO concentration in the tumor and/or serum, after arginine intake may be responsible for these protective effects. Also, arginine consumption may reduce cell proliferation in CRC and it can enhance immune function after remove the tumor. Although the benefits of arginine consumption in CRC patients were reported in previous trials, the finding need replication in well-designed studies before final conclusion.

Citations

Citations to this article as recorded by  
  • Metabolomic analysis reveals key changes in amino acid metabolism in colorectal cancer patients
    Asmaa Ramzy, Taghreed Khaled Abdelmoneim, Menna Arafat, Maha Mokhtar, Ashraf Bakkar, Amany Mokhtar, Wagida Anwar, Sameh Magdeldin, Shymaa Enany
    Amino Acids.2025;[Epub]     CrossRef
  • Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Huang Qin Decoction Preventing Colorectal Cancer Liver Metastasis
    Tiegang Li, Zheng Yan, Mingxuan Zhou, Wenyi Zhao, Fang Zhang, Silin Lv, Yufang Hou, Zifan Zeng, Liu Yang, Yixin Zhou, Zengni Zhu, Xinyi Ren, Min Yang
    Pharmaceuticals.2025; 18(7): 1052.     CrossRef
  • Intestinal microbiota affects the progression of colorectal cancer by participating in the host intestinal arginine catabolism
    Siyang Xu, Yuling Zhang, Xiaoqi Ding, Yijun Yang, Jinge Gao, Ning Zou, Li Lu, Jin He
    Cell Reports.2025; 44(3): 115370.     CrossRef
  • Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis
    Zan Ouyang, Ping Chen, Min Zhang, Sijia Wu, Zongying Qin, Li Zhou
    BMC Cancer.2024;[Epub]     CrossRef
  • Inhibition or promotion, the potential role of arginine metabolism in immunotherapy for colorectal cancer
    Chengyang Chen, Xia Jiang, Zengren Zhao
    All Life.2023;[Epub]     CrossRef
  • Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment
    Eline H. van Roekel, Martijn J. L. Bours, Stéphanie O. Breukink, Michèl Aquarius, Eric T. P. Keulen, Audrey Gicquiau, Sabina Rinaldi, Paolo Vineis, Ilja C. W. Arts, Marc J. Gunter, Michael F. Leitzmann, Augustin Scalbert, Matty P. Weijenberg
    International Journal of Cancer.2023; 152(2): 214.     CrossRef
  • Altered arginine metabolism in colon cancer: A sign of increased proliferative potential of tumor-adjacent tissue
    Branko Brankovic, Goran Stanojevic, Andrej Veljkovic, Gordana Kocic, Milica Nestorovic, Boris Djindjic, Jelena Basic, Ivana Stojanovic
    Archives of Biological Sciences.2022; 74(3): 243.     CrossRef
  • Effect of dapagliflozin and/or L‐arginine on solid tumor model in mice: The interaction between nitric oxide, transforming growth factor‐beta 1, autophagy, and apoptosis
    Ahmed M. Kabel, Hany H. Arab, Maaly A. Abd Elmaaboud
    Fundamental & Clinical Pharmacology.2021; 35(6): 968.     CrossRef
  • Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer
    Vartika Bisht, Katrina Nash, Yuanwei Xu, Prasoon Agarwal, Sofie Bosch, Georgios V. Gkoutos, Animesh Acharjee
    International Journal of Molecular Sciences.2021; 22(11): 5763.     CrossRef
  • Longitudinal associations of physical activity with plasma metabolites among colorectal cancer survivors up to 2 years after treatment
    Eline H. van Roekel, Martijn J. L. Bours, Linda van Delden, Stéphanie O. Breukink, Michèl Aquarius, Eric T. P. Keulen, Audrey Gicquiau, Vivian Viallon, Sabina Rinaldi, Paolo Vineis, Ilja C. W. Arts, Marc J. Gunter, Michael F. Leitzmann, Augustin Scalbert,
    Scientific Reports.2021;[Epub]     CrossRef
  • Watermelon powder supplementation reduces colonic cell proliferation and aberrant crypt foci by upregulating p21Waf1/Cip1 expression
    Yuko Murase Hetrick, Meseret Fesseha, Mee Young Hong
    Journal of Functional Foods.2021; 85: 104667.     CrossRef
  • Alteration of Ornithine Metabolic Pathway in Colon Cancer and Multivariate Data Modelling for Cancer Diagnosis
    Xin Hu, Fangyu Jing, Qingjun Wang, Linyang Shi, Yunfeng Cao, Zhitu Zhu
    Oncologie.2021; 23(2): 203.     CrossRef
  • Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics)
    Nadire Özenver, Thomas Efferth
    Biochemical Pharmacology.2020; 176: 113792.     CrossRef
  • Identifying Significant Metabolic Pathways Using Multi-Block Partial Least-Squares Analysis
    Lingli Deng, Fanjing Guo, Kian-Kai Cheng, Jiangjiang Zhu, Haiwei Gu, Daniel Raftery, Jiyang Dong
    Journal of Proteome Research.2020; 19(5): 1965.     CrossRef
  • 12 View
  • 0 Download
  • 14 Crossref
[English]
Dietary Compliance, Dietary Supplementation and Traditional Remedy Usage of Type 2 Diabetic Patients With and Without Cardiovascular Disease
Mun Chieng Tan, Ooi Chuan Ng, Teck Wee Wong, Anthony Joseph, Abdul Rahman Hejar, Abdul Aziz Rushdan
Clin Nutr Res 2015;4(1):18-31.   Published online December 22, 2014
DOI: https://doi.org/10.7762/cnr.2015.4.1.18

This analytical cross-sectional study examined the nutrient intakes, dietary compliance, dietary supplementation and traditional remedy usage in type 2 diabetes mellitus (T2DM) patients from selected tertiary hospitals in multi-racial Malaysia. We compared the different characteristics of T2DM patients with and without cardiovascular disease (CVD). Socio-demographic status, dietary intakes, dietary supplementation, traditional remedy use, medical history, anthropometric measurements and clinical characteristics were obtained from face-to-face interviews. A total of 313 patients who were treated for T2DM participated in this study, in which 36.1% of them had CVD. The mean age of study subjects was 55.7 ± 9.2 years; mean diabetes duration was 10.1 ± 8.1 years; 52.1% were females; and 47.0% were Malays. The mean total energy intake of the subjects was 1674 ± 694 kcal/day, and patients with CVD consumed higher total calories (p = 0.001). Likewise, the mean carbohydrate, protein and total fat intake of CVD patients were significantly higher than non-CVD patients (p < 0.05), while mean intakes of cholesterol, fibre, minerals and all vitamins were comparable between CVD and non-CVD patients. Regardless of CVD status, a notably high proportion of the subjects did not meet the recommendations of the Medical Nutrition Therapy Guidelines for Type 2 Diabetes for total energy, carbohydrate, protein, total fat, and fibre intakes. Meanwhile, 52.4% used at least one dietary supplement and 12.1% took single traditional remedy or in various combinations. Traditional remedies and supplement intake did not differ between CVD and non-CVD subjects. It is suggested that T2DM patients should be educated based on their personalized dietary intake, dietary supplementation and traditional remedy usage. The recommendations for T2DM patients shall be met to achieve the optimal metabolic goals and minimize the potential diabetic complications.

Citations

Citations to this article as recorded by  
  • Dietary Supplement Intake and Its Association with Cognitive Function, Physical Fitness, Depressive Symptoms, Nutritional Status and Biochemical Indices in a 3-Year Follow-Up Among Community Dwelling Older Adults: A Longitudinal Study
    Divya Vanoh, Suzana Shahar, Hanis Mastura Yahya, Normah Che Din, Arimi Fitri Mat Ludin, Devinder Kaur Ajit Singh, Razinah Sharif, Nor Fadilah Rajab
    Clinical Interventions in Aging.2021; Volume 16: 161.     CrossRef
  • Prevención en diabetes mellitus y riesgo cardiovascular: enfoque médico y nutricional
    Análida Elizabeth Pinilla-Roa, María Del Pilar Barrera-Perdomo
    Revista de la Facultad de Medicina.2018; 66(3): 459.     CrossRef
  • Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia
    Li Min Lim, Megan McStea, Wen Wei Chung, Nuruljannah Nor Azmi, Siti Azdiah Abdul Aziz, Syireen Alwi, Adeeba Kamarulzaman, Shahrul Bahyah Kamaruzzaman, Siew Siang Chua, Reena Rajasuriar, Alessandra Marengoni
    PLOS ONE.2017; 12(3): e0173466.     CrossRef
  • Diet-Related Knowledge and Physical Activity in a Large Cohort of Insulin-Treated Type 2 Diabetes Patients: PROGENS ARENA Study
    Tomasz Klupa, Michał Możdżan, Janina Kokoszka-Paszkot, Magdalena Kubik, Małgorzata Masierek, Margerita Czerwińska, Maciej T. Małecki
    International Journal of Endocrinology.2016; 2016: 1.     CrossRef
  • 5 View
  • 0 Download
  • 4 Crossref